Jones T W, Beaney J
Mech Ageing Dev. 1980 Nov-Dec;14(3-4):417-26. doi: 10.1016/0047-6374(80)90012-3.
Nerve terminals (synaptosomes) isolated from mouse brains accumulate 45Ca2+ at a rate which can be stimulated to increase by immersion in a high K+ saline. Low concentrations of pentobarbitone depress stimulated 45Ca2+ accumulation in a dose-dependent manner. We investigated the effect of 1 mM pentobarbitone on calcium accumulation by synaptosomes isolated from the brains of young and old mice, some of which had been made tolerant to barbiturates, to see if age and tolerance to barbiturate would modify 45Ca2+ accumulation. In the absence of barbiturate, neither advancing age nor barbiturate tolerance could be associated with any significant change in 45Ca2+ uptake by potassium-stimulated or non-stimulated synaptosomes. However, both factors modified the depressant effect of barbiturate. Age and tolerance did not influence resting or potassium-stimulated 45Ca2+ uptake, nor did they influence the suppression by pentobarbitone of resting 45Ca2+ uptake. However, when correcting for suppression of resting uptake by barbiturate, age significantly reduced barbiturate suppression of potassium-stimulated 45Ca2+ uptake. Tolerance significantly reduced this corrected effect of barbiturate in synaptosomes from the 3-month old but not the 24-month-old mice.
从小鼠大脑中分离出的神经末梢(突触体)以一定速率积累45Ca2+,将其浸入高钾盐溶液中可刺激该速率增加。低浓度的戊巴比妥以剂量依赖的方式抑制刺激后的45Ca2+积累。我们研究了1 mM戊巴比妥对从年轻和老年小鼠大脑中分离出的突触体钙积累的影响,其中一些小鼠已对巴比妥类药物产生耐受性,以观察年龄和对巴比妥类药物的耐受性是否会改变45Ca2+积累。在没有巴比妥类药物的情况下,年龄增长和巴比妥类药物耐受性均与钾刺激或未刺激的突触体对45Ca2+的摄取的任何显著变化无关。然而,这两个因素都改变了巴比妥类药物的抑制作用。年龄和耐受性既不影响静息或钾刺激的45Ca2+摄取,也不影响戊巴比妥对静息45Ca2+摄取的抑制作用。然而,在纠正巴比妥类药物对静息摄取的抑制作用后,年龄显著降低了巴比妥类药物对钾刺激的45Ca2+摄取的抑制作用。耐受性显著降低了3月龄小鼠而非24月龄小鼠突触体中巴比妥类药物的这种校正作用。